Expression and Localization of Hypoxia Proteins in Prostate Cancer: Prognostic Implications After Radical Prostatectomy

Urology

Volumn 75, Issue 4, 2010, Pages 786-792

  Jans, Judith ^a   van Dijk, Jessica H ^a   van Schelven, Susanne ^a   van der Groep, Petra ^a   Willems, Sofie H ^a   Jonges, Trudy N ^a   van Diest, Paul J ^a   Bosch, J L H Ruud ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; GENE EXPRESSION REGULATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

AGED; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MIDDLE AGED; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950296962     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.08.024     Document Type: Article

References (27)

1. American Cancer Society. Global cancer facts and figures 2007 (2007)
2. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 98 8 (2006) 529-534
3. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56 5 (1996) 941-943
4. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 19 (1996) 4509-4515
5. Brahimi-Horn M.C., Chiche J., and Pouyssegur J. Hypoxia and cancer. J Mol Med 85 12 (2007) 1301-1307
6. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 3 (1996) 353-364
7. Wang G.L., Jiang B.H., Rue E.A., et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92 12 (1995) 5510-5514
8. Kallio P.J., Pongratz I., Gradin K., et al. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the ARNT transcription factor. Proc Natl Acad Sci U S A 94 11 (1997) 5667-5672
9. Zhong H., Semenza G.L., Simons J.W., et al. Upregulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 28 2 (2004) 88-93
10. Lee J.W., Bae S.H., Jeong J.W., et al. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 36 1 (2004) 1-12
11. Metzen E., Berchner-Pfannschmidt U., Stengel P., et al. Intracellular localisation of human HIF-1alpha hydroxylases: implications for oxygen sensing. J Cell Sci 116 7 (2003) 1319-1326
12. van den Ouden D., Hop W.C., Kranse R., et al. Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate. Br J Urol 79 2 (1997) 203-211
13. Endrizzi J., and Seay T. The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer. BJU Int 85 6 (2000) 696-698
14. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 24 2 (1997) 395-406
15. Zincke H., Oesterling J.E., Blute M.L., et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 152 5 Pt 2 (1994) 1850-1857
16. Catalona W.J., and Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152 5 Pt 2 (1994) 1837-1842
17. Trastour C., Benizri E., Ettore F., et al. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer 120 7 (2007) 1451-1458
18. Dellas K., Bache M., Pigorsch S.U., et al. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol 184 3 (2008) 169-174
19. Enatsu S., Iwasaki A., Shirakusa T., et al. Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung. Eur J Cardio Thorac Surg 29 6 (2006) 891-895
20. Lidgren A., Hedberg Y., Grankvist K., et al. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 50 6 (2006) 1272-1277
21. Vergis R., Corbishley C.M., Norman A.R., et al. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol 9 4 (2008) 342-351
22. Boddy J.L., Fox S.B., Han C., et al. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res 11 21 (2005) 7658-7663
23. Younes M., Brown R.W., Stephenson M., et al. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80 6 (1997) 1046-1051
24. Haber R.S., Rathan A., Weiser K.R., et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83 1 (1998) 34-40
25. Cantuaria G., Fagotti A., Ferrandina G., et al. GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer 92 5 (2001) 1144-1150
26. Chandler J.D., Williams E.D., Slavin J.L., et al. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97 8 (2003) 2035-2042
27. Jokilehto T., Rantanen K., Luukkaa M., et al. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. Clin Cancer Res 12 4 (2006) 1080-1087